Based in Allschwil (Baselland), GlioCART is developing a new type of cell therapy – the first CAR-T cell therapy – designed to target both glioblastoma tumors and the surrounding immune-suppressive ...
After two years of collaborative testing across more than 15 food applications, Denmark-based Oterra, a global leader in natural food colors has entered a commercial agreement with Seprify to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback